Home › Funds › RICE HALL JAMES & ASSOCIATES, LLC › ALKS
RICE HALL JAMES & ASSOCIATES, LLC position in ALKS
ALKERMES PLC · Health Care
RICE HALL JAMES & ASSOCIATES, LLC reported holding 382,152 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 0.82% of its reported portfolio and ranking #40 among its reported holdings. RICE HALL JAMES & ASSOCIATES, LLC has disclosed ALKS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RICE HALL JAMES & ASSOCIATES, LLC's ALKS position evolved
RICE HALL JAMES & ASSOCIATES, LLC first disclosed a stake in ALKS in Q4 2023 at 20,302 shares (US$563K). The position peaked in Q2 2026 at 390,866 shares, worth US$20.5M. Across 12 filings, RICE HALL JAMES & ASSOCIATES, LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 382,152 shares valued at US$15.5M — a reduction of -8,714 shares quarter over quarter.. Notable position changes include a 1874% increase in Q1 2024 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 20.30K | $563.18K | New |
| Q1 2024 | 400.81K | $10.85M | Add |
| Q2 2024 | 467.76K | $11.27M | Add |
| Q3 2024 | 451.66K | $12.64M | Reduce |
| Q4 2024 | 429.93K | $12.36M | Reduce |
| Q1 2025 | 426.58K | $14.09M | Reduce |
| Q2 2025 | 421.88K | $12.07M | Reduce |
| Q3 2025 | 385.34K | $11.56M | Reduce |
| Q4 2025 | 379.46K | $10.62M | Reduce |
| Q1 2026 | 390.34K | $13.80M | Add |
| Q2 2026 | 390.87K | $20.48M | Hold |
| Q3 2026 | 382.15K | $15.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 33 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$263.1M), Deep Track Capital, LP (US$182.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.49M sh · $263.13M · Q3 2026
- Deep Track Capital, LP 4.50M sh · $182.34M · Q3 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 3.15M sh · $127.68M · Q3 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
More on RICE HALL JAMES & ASSOCIATES, LLC
FAQ
How long has RICE HALL JAMES & ASSOCIATES, LLC held ALKS?
RICE HALL JAMES & ASSOCIATES, LLC has disclosed ALKS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is RICE HALL JAMES & ASSOCIATES, LLC's current position in ALKS?
As of Q3 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 382.15K shares of ALKS (ALKERMES PLC), valued at $15.48M, representing 0.82% of its reported portfolio and ranking #40.
Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling ALKS?
In the latest 13F filing (Q3 2026), RICE HALL JAMES & ASSOCIATES, LLC reduced its position in ALKS. The position peaked in Q2 2026 at 390.87K shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.